Increasing Cessation Motivation and Treatment Engagement Among Smokers in Pain
2 other identifiers
interventional
76
1 country
1
Brief Summary
The goal of this study is to develop and pilot test a brief intervention to increase motivation to quit and smoking cessation treatment engagement among smokers with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started May 2016
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 17, 2019
CompletedFirst Posted
Study publicly available on registry
June 25, 2019
CompletedJune 25, 2019
June 1, 2019
2 months
June 17, 2019
June 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Motivation to Quit Smoking
Measured by the Contemplation Ladder and Motivation Rulers. The contemplation ladder is a measure of motivation to quit smoking on an 11 point Visual Analogue Scale. Motivation rulers for smoking cessation consist of three separate NRSs that asses importance of quitting, readiness to quit smoking in the next month, and confidence that "you will quit smoking" in the next month.
30 days
Motivation to engage cessation treatment
Assessed with a single item that asked "would you like to learn about options for treatment to help you quit smoking. If participants answered yes they were then asked whether they were interested and planned to enroll in the following types of treatment in the next 30 days: medication/primary care, Quitline, behavioral health, or none of the above.
30 days
Knowledge of pain-smoking interrelations
Using the Pain and Smoking Questionnaire (PSQ) which is a 25 total item questionnaire to asses knowledge of interrelations between pain and tobacco smoking. 17 items assess knowledge of associations between smoking and multiple health conditions. 8 Separate items assess specific knowledge of pain-smoking interrelations such as pain related impairment, whether smoking can cause chronic pain, reduce effectiveness of prescription pain medications, provide analgesic effects, or help to distract from pain.
30 days
Secondary Outcomes (2)
Smoking behavior
30 days
Use of cessation treatment
30 days
Study Arms (2)
Tailored intervention
EXPERIMENTALBrief Motivational Smoking Intervention
Control
EXPERIMENTALIntervention consistent with standard clinical practice (Control)
Interventions
Brief motivational smoking intervention tailored to address smoking in the context of pain. Included a novel pain-smoking psycho education component, personalized feedback component, and elicitation of participant's pain-related goals to develop discrepancy between continued smoking and desired pain outcomes.
The Ask-Advise-Refer intervention is commonly used in standard clinical practice.
Eligibility Criteria
You may qualify if:
- Current daily cigarette smoking (at least 10/day)
- Current moderate-very sever chronic pain with a numerical pain rating of at least 4/10
- At least 18 years of age
You may not qualify if:
- Current active attempt to quit smoking
- Enrollment in smoking cessation treatment or use of a smoking cessation medication
- Less than 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Syracuse Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Joseph Ditre
Syracuse, New York, 13210, United States
Related Publications (1)
Zale EL, Maisto SA, De Vita MJ, Hooten WM, Ditre JW. Increasing cessation motivation and treatment engagement among smokers in pain: A pilot randomized controlled trial. Exp Clin Psychopharmacol. 2021 Dec;29(6):593-604. doi: 10.1037/pha0000424. Epub 2020 Aug 6.
PMID: 32757595DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Zale, PhD
Syracuse University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2019
First Posted
June 25, 2019
Study Start
May 10, 2016
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
June 25, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data with other researchers.